Reply to: PREDICT underestimates survival of patients with HER2-positive early-stage breast cancer.

ABSTRACT:

SUBMITTER: Agostinetto E 

PROVIDER: S-EPMC10020562 | biostudies-literature | 2023 Mar

REPOSITORIES: biostudies-literature